Clinical efficacy and safety of flumatinib versus dasatinib combined with multi-drug chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia

Authors: Qian Liu, Tie Rong Bian, Zhi Yuan Li, Hong Yun Xing

Source: Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S71-S78 (2024)

Subject Terms: Philadelphia chromosome-positive Acute lymphoblastic leukemia, Flumatinib, Dasatinib, Efficacy, Adverse reactions, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2531137924000130; https://doaj.org/toc/2531-1379

Access URL: https://doaj.org/article/511c18057fd14c84a5d79b94dd1ae01b

Bilateral optic nerve infiltration and leukemic retinopathy as initial signs of leukemia relapse with central nervous system involvement in an adult: a case report

Authors: Yisai Wang, Ling Zhu, Hongtao Wang, Zhen Li, Ruomeng Bai, Qinghua Wei, Lin Huang, Ying Xu, Songguo Li, Hui Chen

Source: BMC Ophthalmology, Vol 24, Iss 1, Pp 1-5 (2024)

Subject Terms: Case report, Philadelphia chromosome-positive acute lymphoblastic leukemia, Optic nerve infiltration, Leukemic retinopathy, Relapse, Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2415

Access URL: https://doaj.org/article/d60ed5f294d34a3b972648231dc125a4

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia

Authors: Xiaoxia Wu, Shenqi Lu, Xinhui Zhang, Zhen Yang, Aining Sun, Depei Wu, Huifen Zhou, Miao Miao

Source: Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)

Subject Terms: Blinatumomab, Philadelphia chromosome–like acute lymphoblastic leukemia, Philadelphia chromosome‐positive acute lymphoblastic leukemia, tyrosine kinase inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/0adf6bb1a01b4097a34a3a5440db646a

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients

Authors: Jeffrey Baron, Manu R. Pandey, Elizabeth A. Griffiths, Eunice S. Wang

Source: Leukemia Research Reports, Vol 22, Iss , Pp 100474- (2024)

Subject Terms: Philadelphia chromosome positive acute lymphoblastic leukemia, Jehovah's witness, Tyrosine kinase inhibitors, Low-dose chemotherapy, Growth factors, Supportive care management, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2213048924000645; https://doaj.org/toc/2213-0489

Access URL: https://doaj.org/article/5f3b0f6e8c5c4110ad61e57d0af45962

Autologous peripheral blood stem cell transplantation for Philadelphia chromosome‐positive acute lymphoblastic leukemia is safe but poses challenges for long‐term maintenance of molecular remission: Results of the Auto‐Ph17 study

Authors: Satoshi Nishiwaki, Isamu Sugiura, Takahiko Sato, Miki Kobayashi, Masahide Osaki, Masashi Sawa, Yoshitaka Adachi, Motohito Okabe, Shigeki Saito, Takanobu Morishita, Akio Kohno, Takahiro Nishiyama, Hiroatsu Iida, Shingo Kurahashi, Yachiyo Kuwatsuka, Daisuke Sugiyama, Sachiko Ito, Hiroyoshi Nishikawa, Hitoshi Kiyoi

Source: eJHaem, Vol 4, Iss 2, Pp 358-369 (2023)

Subject Terms: autologous peripheral blood stem cell transplantation, dasatinib, Philadelphia chromosome‐positive acute lymphoblastic leukemia, regulatory T cell, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2688-6146

Access URL: https://doaj.org/article/7022b7c0b35b470e88c8ad6230bbfcb4

Is higher lymphocyte count a potential strategy for preventing chronic kidney disease in patients receiving long-term dasatinib treatment?

Authors: Hirokazu Nakayama, Hiromitsu Iizuka, Toshiaki Kato, Kensuke Usuki

Source: Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-7 (2023)

Subject Terms: Dasatinib, Chronic kidney disease, Lymphocyte count, Neutrophil–lymphocyte count ratio, Philadelphia chromosome positive acute lymphoblastic leukemia and chronic myeloid leukemia, Therapeutics. Pharmacology, RM1-950, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://doaj.org/toc/2055-0294

Access URL: https://doaj.org/article/a5f1326852644bdd9d71aae24699f5dd

Pneumocystis jiroveci Pneumonia secondary to tyrosine kinase inhibitor with blinatumomab therapy: A case report

Authors: Wang, Xiaoning ^{a, ⁎}, Li, Hao ^b, Li, Jing ^a, Zhang, Mei ^a, He, Pengcheng ^a

Source: In International Immunopharmacology February 2023 115

Basic and clinical study of efficacy and adverse effects of flumatinib in Ph+ ALL

Authors: Jun Wang, Jiafei Wu, Yijing Wang, Boyue Zheng, Yu Wang, Chuanyan Jiang, Mengying Zou, Hui Li

Source: Frontiers in Pharmacology, Vol 14 (2023)

Subject Terms: philadelphia chromosome-positive acute lymphoblastic leukemia, flumatinib, treatment, new diagnosis, effect, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2023.1178393/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/170cd0819a134c20abda6415cc425e4a

Comparison of allogeneic hematopoietic stem cell transplantation and TKI combined with chemotherapy for adult philadelphia chromosome positive acute lymphoblastic leukemia: a systematic review and meta‐analysis

Authors: Qiang Zeng, Bing Xiang, Zhigang Liu

Source: Cancer Medicine, Vol 10, Iss 24, Pp 8741-8753 (2021)

Subject Terms: allogeneic hematopoietic stem cell transplantation, meta‐analysis, Philadelphia chromosome positive acute lymphoblastic leukemia, tyrosine kinase inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/85a15a273d1b409abcac91078130642f

Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reports

Authors: Junichiro Yuda, Nobuhiko Yamauchi, Ayumi Kuzume, Yong-Mei Guo, Nobue Sato, Yosuke Minami

Source: Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-6 (2021)

Subject Terms: Relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia, Blinatumomab, Ponatinib, Tyrosine kinase inhibitor, BCR–ABL compound mutations, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1752-1947

Access URL: https://doaj.org/article/597cbb906d174e52b7970f3b4728ed99

Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia

Authors: Satoshi Nishiwaki, Isamu Sugiura, Daisuke Koyama, Yukiyasu Ozawa, Masahide Osaki, Yuichi Ishikawa, Hitoshi Kiyoi

Source: Biomarker Research, Vol 9, Iss 1, Pp 1-4 (2021)

Subject Terms: eXtreme gradient boosting algorithm, Machine learning, Philadelphia chromosome-positive acute lymphoblastic leukemia, Prognostic factor, Survival stratification, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2050-7771

Access URL: https://doaj.org/article/daa0493c46a44ee9abff03074f4a1788

Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Authors: Kazuki Tanimura, Kai Yamasaki, Yuki Okuhiro, Kota Hira, Chika Nitani, Keiko Okada, Hiroyuki Fujisaki, Kana Matsumoto, Junichi Hara

Source: Case Reports in Oncology, Vol 14, Iss 1, Pp 24-28 (2021)

Subject Terms: philadelphia chromosome-positive acute lymphoblastic leukemia, ponatinib, plasma concentration, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.karger.com/Article/FullText/511071; https://doaj.org/toc/1662-6575

Access URL: https://doaj.org/article/2831b36850924622a7819ce0abc83cf9

Inotuzumab ozogamicin and blinatumomab sequential therapy for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

Authors: Tomoaki Ueda, Kentaro Fukushima, Shinsuke Kusakabe, Koki Yoshida, Makiko Suga, Ritsuko Nakai, Midori Koike, Akihisa Hino, Keigo Akuta, Jun Toda, Yasuhiro Nagate, Yukiko Doi, Jiro Fujita, Takafumi Yokota, Naoki Hosen

Source: Leukemia Research Reports, Vol 17, Iss , Pp 100294- (2022)

Subject Terms: Philadelphia chromosome-positive acute lymphoblastic leukemia, Allogeneic stem cell transplantation, Inotuzumab ozogamicin, Blinatumomab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2213048922000061; https://doaj.org/toc/2213-0489

Access URL: https://doaj.org/article/eb07acd9618f45c99bd910840ab0f31e

Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features

Authors: Satoshi Nishiwaki, Jeong Hui Kim, Masafumi Ito, Matsuyoshi Maeda, Yusuke Okuno, Daisuke Koyama, Yukiyasu Ozawa, Masaharu Gunji, Masahide Osaki, Kunio Kitamura, Yoko Ushijima, Yuichi Ishikawa, Koichi Miyamura, Isamu Sugiura, Hitoshi Kiyoi

Source: Frontiers in Oncology, Vol 10 (2020)

Subject Terms: BCR-ABL-expressing lineage, multi-lineage, multipotent progenitor, Philadelphia chromosome-positive acute lymphoblastic leukemia, uni-lineage, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2020.586567/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/3ae04fa916b94ae6a5e9a87736b42a35

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation

Authors: Farnsworth Paul, Ward David, Reddy Vijay

Source: Experimental Hematology & Oncology, Vol 1, Iss 1, p 29 (2012)

Subject Terms: Philadelphia chromosome positive acute lymphoblastic leukemia (PH + ALL), Nilotinib, Extracorporeal photopheresis (ECP), Graft-versus-host disease (GVHD), Graft-versus-leukemia effect (GVL), Hematopoietic stem cell transplantation (HSCT), Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.ehoonline.org/content/1/1/29; https://doaj.org/toc/2162-3619

Access URL: https://doaj.org/article/6d319e38146d404eae5a3e8b6329f71e

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.